Selective antidopaminergic effects of S(+)N-n-propylnoraporphines in limbic versus extrapyramidal sites in rat brain: comparisons with typical and atypical antipsychotic agents

1991 ◽  
Vol 103 (3) ◽  
pp. 323-329 ◽  
Author(s):  
Alexander Campbell ◽  
Sylva Yeghiayan ◽  
Ross J. Baldessarini ◽  
John L. Neumeyer
Keyword(s):  
Rat Brain ◽  
Atypical Antipsychotic ◽  
Antipsychotic Agents ◽  
Atypical Antipsychotic Agents

Adverse Effects of Atypical Antipsychotic Agents and Their Effects on Quality of Life

2004 ◽  
Vol 24 (7) ◽  
pp. 843-847 ◽  
Author(s):  
Beth M. Dubisar ◽  
Steven C. Stoner ◽  
James Reynolds ◽  
Rintu Khan ◽  
Leonard Ramlatchman
Keyword(s):  
Quality Of Life ◽  
Adverse Effects ◽  
Atypical Antipsychotic ◽  
Antipsychotic Agents ◽  
Atypical Antipsychotic Agents

scholarly journals Weight loss in overweight patients maintained on atypical antipsychotic agents

2006 ◽  
Vol 30 (6) ◽  
pp. 1011-1016 ◽  
Author(s):  
F Centorrino ◽  
J J Wurtman ◽  
K A Duca ◽  
V H Fellman ◽  
K V Fogarty ◽  
...  
Keyword(s):  
Weight Loss ◽  
Atypical Antipsychotic ◽  
Antipsychotic Agents ◽  
Atypical Antipsychotic Agents

Risk of discontinuation of atypical antipsychotic agents in the treatment of schizophrenia

2008 ◽  
Vol 98 (1-3) ◽  
pp. 8-15 ◽  
Author(s):  
C. Daniel Mullins ◽  
Nour A. Obeidat ◽  
Brian J. Cuffel ◽  
John Naradzay ◽  
Antony D. Loebel
Keyword(s):  
Atypical Antipsychotic ◽  
Antipsychotic Agents ◽  
Atypical Antipsychotic Agents

Therapeutic efficacy of putative atypical antipsychotic agents

1989 ◽  
Vol 2 (1-2) ◽  
pp. 196
Author(s):  
RichardL. Borison ◽  
BruceI. Diamond ◽  
Denise Evans ◽  
D.Durrell Evans ◽  
Hany Elia ◽  
...  
Keyword(s):  
Atypical Antipsychotic ◽  
Therapeutic Efficacy ◽  
Antipsychotic Agents ◽  
Atypical Antipsychotic Agents

Improving Adherence to Atypical Antipsychotic Agent Screening Guidelines in Pediatric Patients: A Quality Improvement Project Within an Integrated Community Mental Health Setting

2018 ◽  
Vol 24 (4) ◽  
pp. 352-359 ◽  
Author(s):  
Elishia L. Featherston ◽  
Sharolyn Dihigo ◽  
Richard E. Gilder
Keyword(s):  
Mental Health ◽  
Quality Improvement ◽  
Community Mental Health ◽  
Children And Adolescents ◽  
Atypical Antipsychotic ◽  
Antipsychotic Agents ◽  
Mental Health Setting ◽  
Improvement Project ◽  
Screening Guidelines ◽  
Atypical Antipsychotic Agents

Background: Approximately 14% to 20% of children and adolescents have a mental health problem. Atypical antipsychotic agents are used to treat behavioral, emotional, and mental health problems in children and adolescents. A discrepancy between best practices and actual practices exists. Objective: The purpose of this quality improvement project was to increase adherence above baseline, through implementation of a checklist, to recommended screening guidelines in children, ages 4 to 18, prescribed atypical antipsychotic agents over 12 weeks. Design/Results: Aggregate comparison of the mean ranks of scores were tested with the Mann–Whitney U test, U = 1,087.5, n1 = n2 = 70, total N =140, p < .001. Variables of body mass index, blood pressure, waist circumference, fasting glucose, fasting lipids, personal history, and family history were observed and tested using the chi-square with Fisher’s exact tests and are significant at or above 99% confidence level ( p < .01). Conclusion: Educating mental health providers, child and adolescent psychiatrists, and psychiatric mental health nurse practitioners on recommended screening guidelines and implementing a checklist had a measurable effect on increasing adherence to the recommended screening guidelines in a community mental health setting.

Sign in / Sign up

Export Citation Format

Share Document